Paying users zone. Data is covered by .

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.

$15.99


Historical Valuation Ratios (Summary)

Bristol-Myers Squibb Co., historical price multiples (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Price to earnings (P/E)
Price to operating profit (P/OP)
Price to sales (P/S)
Price to book value (P/BV)
Ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Bristol-Myers Squibb Co.'s P/E ratio increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Bristol-Myers Squibb Co.'s P/OP ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Bristol-Myers Squibb Co.'s P/S ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company's required rate of return and its actual rate of return. Bristol-Myers Squibb Co.'s P/BV ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top


Price to Earnings (P/E)

Bristol-Myers Squibb Co., historical P/E calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
No. shares of common stock outstanding1
Selected Financial Data (USD $)
Net earnings (loss) attributable to BMS (in millions)
Earnings per share (EPS)3
Share price1, 2
P/E ratio4

1 Data adjusted for splits and stock dividends.

2 Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

3 EPS = (Net earnings (loss) attributable to BMSQ1 2018 + Net earnings (loss) attributable to BMSQ4 2017 + Net earnings (loss) attributable to BMSQ3 2017 + Net earnings (loss) attributable to BMSQ2 2017) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

4 P/E ratio = Share price ÷ EPS
= ÷ =

Ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Bristol-Myers Squibb Co.'s P/E ratio increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.

Top


Price to Operating Profit (P/OP)

Bristol-Myers Squibb Co., historical P/OP calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
No. shares of common stock outstanding1
Selected Financial Data (USD $)
Operating income (in millions)
Operating profit per share3
Share price1, 2
P/OP ratio4

1 Data adjusted for splits and stock dividends.

2 Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

3 Operating profit per share = (Operating incomeQ1 2018 + Operating incomeQ4 2017 + Operating incomeQ3 2017 + Operating incomeQ2 2017) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

4 P/OP ratio = Share price ÷ Operating profit per share
= ÷ =

Ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Bristol-Myers Squibb Co.'s P/OP ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top


Price to Sales (P/S)

Bristol-Myers Squibb Co., historical P/S calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
No. shares of common stock outstanding1
Selected Financial Data (USD $)
Revenues (in millions)
Sales per share3
Share price1, 2
P/S ratio4

1 Data adjusted for splits and stock dividends.

2 Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

3 Sales per share = (RevenuesQ1 2018 + RevenuesQ4 2017 + RevenuesQ3 2017 + RevenuesQ2 2017) ÷ No. shares of common stock outstanding
= ( + + + ) ÷ =

4 P/S ratio = Share price ÷ Sales per share
= ÷ =

Ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Bristol-Myers Squibb Co.'s P/S ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top


Price to Book Value (P/BV)

Bristol-Myers Squibb Co., historical P/BV calculation (quarterly data)

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
No. shares of common stock outstanding1
Selected Financial Data (USD $)
Total Bristol-Myers Squibb Company shareholders' equity (in millions)
Book value per share (BVPS)3
Share price1, 2
P/BV ratio4

1 Data adjusted for splits and stock dividends.

2 Close price on the filing date of Bristol-Myers Squibb Co.'s Quarterly or Annual Report.

Q1 2018 Calculations

3 BVPS = Total Bristol-Myers Squibb Company shareholders' equity ÷ No. shares of common stock outstanding
= ÷ =

4 P/BV ratio = Share price ÷ BVPS
= ÷ =

Ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company's required rate of return and its actual rate of return. Bristol-Myers Squibb Co.'s P/BV ratio increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.

Top